Next-Generation Sequencing (NGS) Market by Product, Services, & Application - Global Forecasts to 2022

  • ID: 4196172
  • Report
  • Region: Global
  • 216 Pages
  • Markets and Markets
1 of 6
The Global Next-Generation Sequencing Market is Estimated to Register a CAGR of 20.5% from 2017 to 2022 to Reach USD 12.45 Billion by 2022

FEATURED COMPANIES

  • BGI
  • Eurofins Scientific SE
  • Genewiz, Inc.
  • Macrogen, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • MORE

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market.

On the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market.

On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina’s systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.

Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing & developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases.

On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. For instance, in November 2016, Illumina, Inc. entered into an agreement with Mayo Clinic (U.S.) to install its BaseSpace Clarity LIMS in Mayo’s specific laboratories.
 
Geographically, the NGS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2017, followed by Europe. The market in North America is primarily driven by the technological advancements, availability of commercial solutions for NGS data analysis, and the strong presence of key players in this region. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, due to the improving healthcare infrastructure and favorable government initiatives in this region.

The global NGS market is highly competitive, with a large number of global and local players. In 2016, the global NGS market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.), and together held the majority share of the NGS platforms market. New product launches, product enhancements, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market.

Research Coverage

This report studies the next-generation sequencing (NGS) market based on product & service, application, technology, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis-industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the next-generation sequencing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the next-generation sequencing market. The report analyzes the next generation sequencing market based on product & service, application, technology, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the next-generation sequencing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various next-generation sequencing products and services across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the next-generation sequencing market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the next-generation sequencing market.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • BGI
  • Eurofins Scientific SE
  • Genewiz, Inc.
  • Macrogen, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Stakeholders

2 Research Methodology
    2.1 Research Approach
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Data
                    2.2.2.1 Breakdown of Primaries
                    2.2.2.2 Key Data From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 Next-Generation Sequencing (NGS) Services Market Overview
    4.2 Global NGS Services Market, By Type, 2015 vs 2017 vs 2022 (USD Million)
    4.3 Geographic Analysis: NGS Services Market, By Technology (2017)
    4.4 NGS Services Market, By Application
    4.5 Global NGS Services Market, By End User, 2017 vs 2022
    4.6 Geographical Snapshot of the NGS Services Market

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Declining Price of Sequencing
                    5.2.1.2 High Cost of Sequencing Infrastructure
                    5.2.1.3 Need for Skilled Professionals for Efficient NGS Sample Preparation and Analysis
                    5.2.1.4 Sequencing Services, the Preferred Option for NGS Applications With Low Throughput Requirements
                    5.2.1.5 Technological Advancements in the Field of Sequencing
           5.2.2 Restraints
                    5.2.2.1 Installation of In-House Sequencing Facilities in Hospitals and Universities
           5.2.3 Opportunities
                    5.2.3.1 Analysis of Complex Sequencing Data
                    5.2.3.2 Increasing Applications in Cancer and Agrigenomics Research
           5.2.4 Challenges
                    5.2.4.1 Accuracy & Standardization Concerns in Diagnostic Testing
                    5.2.4.2 Ethical Issues Related to NIPT

6 Global Next-Generation Sequencing Services Market, By Technology
    6.1 Introduction
    6.2 Sequencing By Synthesis
    6.3 Ion Semiconductor Sequencing
    6.4 Single-Molecule Real-Time Sequencing
    6.5 Nanopore Sequencing

7 Global NGS Services Market, By Service Type
    7.1 Introduction
    7.2 Targeted Resequencing & Custom Gene Panels
    7.3 RNA-Seq
    7.4 De Novo Sequencing
    7.5 Exome Sequencing
    7.6 Chip-Seq
    7.7 Whole-Genome Sequencing
    7.8 Methyl-Seq
    7.9 Other Services

8 Next-Generation Sequencing Services Market, By Application
    8.1 Introduction
    8.2 Diagnostics
           8.2.1 Oncology
           8.2.2 Infectious Diseases
           8.2.3 Rare Genetic Disorders
           8.2.4 Reproductive Health
           8.2.5 Other Diagnostic Applications
    8.3 Drug Discovery
    8.4 Biomarker Discovery
    8.5 Agriculture & Animal Research
    8.6 Other Applications

9 Next-Generation Sequencing Services Market, By End User
    9.1 Introduction
           9.1.1 Academic & Government Institutes and Research Centers
           9.1.2 Hospitals & Clinics
           9.1.3 Pharmaceutical & Biotechnology Companies
           9.1.4 Other End Users

10 Global Next-Generation Sequencing Services Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape
     11.1 Introduction
     11.2 Market Ranking Analysis
     11.3 Competitive Leadership Benchmarking
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Strength of Product Portfolio (For 25 Players)
     11.5 Business Strategy Excellence (For 25 Players)

*Top 25 Companies Analyzed for This Study are - Illumina, Inc., BGI, Eurofins Scientific SE, Perkinelmer, Inc., Qiagen N.V., Gatc Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, Wuxi Apptec, Genewiz, Inc., Takara Bio Inc., Scigenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics Biosci & Tech. Co., Ltd., Zymo Research Corp, Source Bioscience, Integragen Sa, Centogene AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.

12 Company Profiles
     12.1 Introduction
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
     12.2 BGI
     12.3 Illumina, Inc.
     12.4 Perkinelmer, Inc.
     12.5 Eurofins Scientific SE
     12.6 Gatc Biotech AG
     12.7 Macrogen, Inc.
     12.8 Qiagen N.V.
     12.9 Genotypic Technology Pvt. Ltd.
     12.10 Genewiz, Inc.
     12.11 DNA Link, Inc.
     12.12 Takara Bio Inc. (Part of Takara Holding Company Inc.)
     12.13 Scigenom Labs Pvt. Ltd
     12.14 Novogene Corporation
     12.15 Personalis, Inc.
     12.16 LGC Limited (A Part of KKR & Co. L.P.)

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

List of Tables
Table 1 NGS Services Market, By Region, 2015-2022 (USD Million)
Table 2 NGS Services Market for Sequencing By Synthesis, By Region, 2015-2022 (USD Million)
Table 3 NGS Services Market for Ion Semiconductor Sequencing, By Region, 2015-2022 (USD Million)
Table 4 NGS Services Market for Single-Molecule Real-Time Sequencing, By Region, 2015-2022 (USD Million)
Table 5 NGS Services Market for Nanopore Sequencing, By Region, 2015-2022 (USD Million)
Table 6 NGS Services Market, By Type, 2015-2022 (USD Million)
Table 7 Targeted Sequencing Services Market, By Region, 2015-2022 (USD Million)
Table 8 RNA-Seq Services Market, By Region, 2015-2022 (USD Million)
Table 9 De Novo Sequencing Services Market, By Region, 2015-2022 (USD Million)
Table 10 Exome Sequencing Services Market, By Region, 2015-2022 (USD Million)
Table 11 Chip-Seq Services Market, By Region, 2015-2022 (USD Million)
Table 12 Whole-Genome Sequencing Services Market, By Region, 2015-2022 (USD Million)
Table 13 Methyl-Seq Services Market, By Region, 2015-2022 (USD Million)
Table 14 Other NGS Services Market, By Region, 2015-2022 (USD Million)
Table 15 Next-Generation Sequencing Services Market, By Application, 2015-2022 (USD Million)
Table 16 NGS Diagnostic Services Market, By Application, 2015-2022 (USD Million)
Table 17 Next-Generation Sequencing Services Market for Diagnostic Applications, By Region, 2015-2022 (USD Million)
Table 18 Next-Generation Sequencing Services Market for Drug Discovery, By Region, 2015-2022 (USD Million)
Table 19 Next-Generation Sequencing Services Market for Biomarker Discovery, By Region, 2015-2022 (USD Million)
Table 20 Next-Generation Sequencing Services Market for Agriculture and Animal Research, By Region, 2015-2022 (USD Million)
Table 21 Next-Generation Sequencing Services Market for Other Applications, By Region, 2015-2022 (USD Million)
Table 22 Next-Generation Sequencing Services Market, By End User, 2015-2022 (USD Million)
Table 23 Next-Generation Sequencing Services Market for Academic & Government Institutes and Research Centers, By Region, 2015-2022 (USD Million)
Table 24 Next-Generation Sequencing Services Market for Hospitals & Clinics, By Region, 2015-2022 (USD Million)
Table 25 Next-Generation Sequencing Services Market for Pharmaceutical & Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 26 Next-Generation Sequencing Services Market for Other End Users, By Region, 2015-2022 (USD Million)
Table 27 Next-Generation Sequencing Services Market, By Region, 2015-2022 (USD Million)
Table 28 North America: Next-Generation Sequencing Services Market, By Country, 2015-2022 (USD Million)
Table 29 North America: Next-Generation Sequencing Services Market, By Type, 2015-2022 (USD Million)
Table 30 North America: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 31 North America: Next-Generation Sequencing Services Market, By Application, 2015-2022 (USD Million)
Table 32 North America: Next-Generation Sequencing Services Market, By End User, 2015-2022 (USD Million)
Table 33 U.S.: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 34 Canada: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 35 Europe: Next-Generation Sequencing Services Market, By Country, 2015-2022 (USD Million)
Table 36 Europe: Next-Generation Sequencing Services Market, By Type, 2015-2022 (USD Million)
Table 37 Europe: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 38 Europe: Next-Generation Sequencing Services Market, By Application, 2015-2022 (USD Million)
Table 39 Europe: Next-Generation Sequencing Services Market, By End User, 2015-2022 (USD Million)
Table 40 Germany: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 41 U.K.: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 42 France: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 43 RoE: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 44 Asia-Pacific: Next-Generation Sequencing Services Market, By Country, 2015-2022 (USD Million)
Table 45 Asia-Pacific: Next-Generation Sequencing Services Market, By Type, 2015-2022 (USD Million)
Table 46 Asia-Pacific: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 47 Asia-Pacific: Next-Generation Sequencing Services Market, By Application, 2015-2022 (USD Million)
Table 48 Asia-Pacific: Next-Generation Sequencing Services Market, By End User, 2015-2022 (USD Million)
Table 49 China: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 50 Japan: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 51 India: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 52 RoAPAC: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 53 RoW: Next-Generation Sequencing Services Market, By Type, 2015-2022 (USD Million)
Table 54 RoW: Next-Generation Sequencing Services Market, By Technology, 2015-2022 (USD Million)
Table 55 RoW: Next-Generation Sequencing Services Market, By Application, 2015-2022 (USD Million)
Table 56 RoW: Next-Generation Sequencing Services Market, By End User, 2015-2022 (USD Million)

List of Figures
Figure 1 Global NGS Services Market: Research Approach
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 NGS Services Market: Bottom-Up Approach
Figure 5 NGS Services Market: Top-Down Approach
Figure 6 NGS Services Market: Data Triangulation
Figure 7 Next-Generation Sequencing Services Market, By Type, 2017 vs 2022
Figure 8 Next-Generation Sequencing Services Market, By Technology, 2017 vs 2022 (USD Million)
Figure 9 Next-Generation Sequencing Services Market, By Application, 2017 vs 2022 (USD Million)
Figure 10 Next-Generation Sequencing Services Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Geographical Snapshot of the Next-Generation Sequencing Services Market
Figure 12 Increasing Applications of NGS in Cancer and Agrigenomics Research to Offer Significant Growth Opportunities During the Forecast Period
Figure 13 North America to Dominate the NGS Services Market in 2017
Figure 14 Agriculture & Animal Research Segment to Register the Highest Growth Rate in the NGS Services Market Between 2017 & 2022
Figure 15 Academic & Government Institutes and Research Centers Segment Will Continue to Dominate the Global NGS Services Market in 2022
Figure 16 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 17 Next-Generation Sequencing Services Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Human Whole-Genome Sequencing Cost Estimated By the National Human Genome Research Institute
Figure 19 Nanopore Sequencing to Register the Highest Growth During the Forecast Period (2017 to 2022)
Figure 20 NGS Services Market, By Technology, 2015-2022 (USD Million)
Figure 21 Targeted Resequencing/Custom Gene Panels Segment Will Continue to Dominate the Global Next-Generation Sequencing Services Market in 2022
Figure 22 Diagnostics Segment Will Continue to Dominate the Global Next-Generation Sequencing Services Market in 2022
Figure 23 Growth in Number of Genetic Tests (2012-2016)
Figure 24 Increasing Publications Related to Biomarker Discovery Based on NGS During 2011-2016
Figure 25 Academic & Government Institutes and Research Centers to Register the Highest CAGR in the Forecast Period
Figure 26 Next-Generation Sequencing Services Market, By Region
Figure 27 North America: Next-Generation Sequencing Services Market Snapshot
Figure 28 Europe: Next-Generation Sequencing Services Market Snapshot
Figure 29 Asia-Pacific: Next-Generation Sequencing Services Market Snapshot
Figure 30 RoW: Next-Generation Sequencing Services Market Snapshot
Figure 31 BGI, Eurofins Scientific Se, and Macrogen Were the Leading Providers for NGS Services Worldwide in 2016
Figure 32 NGS Services Market (Global) Competitive Leadership Mapping, 2017
Figure 33 Illumina, Inc.: Company Snapshot (2016)
Figure 34 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 35 Eurofins Scientific Se: Company Snapshot (2016)
Figure 36 Macrogen, Inc.: Company Snapshot (2015)
Figure 37 Qiagen N.V.: Company Snapshot (2016)
Figure 38 Takara Bio Inc.: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • BGI
  • DNA Link, Inc.
  • Eurofins Scientific SE
  • Gatc Biotech AG
  • Genewiz, Inc.
  • Genotypic Technology Pvt. Ltd.
  • Illumina, Inc.
  • LGC Limited (A Part of KKR & Co. L.P.)
  • Macrogen, Inc.
  • Novogene Corporation
  • Perkinelmer, Inc.
  • Personalis, Inc.
  • Qiagen N.V.
  • Scigenom Labs Pvt. Ltd
  • Takara Bio Inc. (Part of Takara Holding Company Inc.)
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll